Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001025291 | SCV001187452 | likely benign | Hereditary cancer-predisposing syndrome | 2019-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002271611 | SCV002555612 | likely benign | not specified | 2022-06-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002551920 | SCV003306225 | likely benign | Familial adenomatous polyposis 2 | 2022-02-11 | criteria provided, single submitter | clinical testing |